Skip to main content
Top
Published in: Medical Microbiology and Immunology 6/2015

01-12-2015 | Original Investigation

ExoU-induced redox imbalance and oxidative stress in airway epithelial cells during Pseudomonas aeruginosa pneumosepsis

Authors: Luiz Gonzaga da Cunha Jr., Miriam Francisca Ferreira, João Alfredo de Moraes, Patricia Alves Reis, Hugo Caire Castro-Faria-Neto, Christina Barja-Fidalgo, Maria-Cristina Plotkowski, Alessandra Mattos Saliba

Published in: Medical Microbiology and Immunology | Issue 6/2015

Login to get access

Abstract

ExoU is a potent proinflammatory toxin produced by Pseudomonas aeruginosa, a major agent of severe lung infection and sepsis. Because inflammation is usually associated with oxidative stress, we investigated the effect of ExoU on free radical production and antioxidant defense mechanisms during the course of P. aeruginosa infection. In an experimental model of acute pneumonia, ExoU accounted for increased lipid peroxidation in mice lungs as soon as 3 h after intratracheal instillation of PA103 P. aeruginosa strain. The contribution of airway cells to the generation of a redox imbalance was assessed by in vitro tests carried out with A549 airway epithelial cells. Cultures infected with the ExoU-producing PA103 P. aeruginosa strain produced significantly increased concentrations of lipid hydroperoxides, 8-isoprostane, reactive oxygen intermediates, peroxynitrite and nitric oxide (NO), when compared to cells infected with exoU-deficient mutants. Overproduction of NO by PA103-infected cells likely resulted from overexpression of both inducible and endothelial NO synthase isoforms. PA103 infection was also associated with a significantly increased activity of superoxide dismutase (SOD) and decreased levels of reduced glutathione (GSH), a major antioxidant compound. Our findings unveil another potential mechanism of tissue damage during infection by ExoU-producing P. aeruginosa strains.
Literature
1.
go back to reference Rocha M, Herance R, Rovira S, Hernández-Mijares A, Victor VM (2012) Mitochondrial dysfunction and antioxidant therapy in sepsis. Infect Disord Drug Targets 12:161–178CrossRefPubMed Rocha M, Herance R, Rovira S, Hernández-Mijares A, Victor VM (2012) Mitochondrial dysfunction and antioxidant therapy in sepsis. Infect Disord Drug Targets 12:161–178CrossRefPubMed
2.
go back to reference Günther A, Walmrath D, Grimminger F, Seeger W (2001) Pathophysiology of acute lung injury. Semin Respir Crit Care Med 27:247–258CrossRef Günther A, Walmrath D, Grimminger F, Seeger W (2001) Pathophysiology of acute lung injury. Semin Respir Crit Care Med 27:247–258CrossRef
3.
4.
go back to reference Guéraud F, Atalay M, Bresgen N, Cipak A, Eckl PM, Huc L et al (2010) Chemistry and biochemistry of lipid peroxidation products. Free Radic Res 44:1098–1124CrossRefPubMed Guéraud F, Atalay M, Bresgen N, Cipak A, Eckl PM, Huc L et al (2010) Chemistry and biochemistry of lipid peroxidation products. Free Radic Res 44:1098–1124CrossRefPubMed
5.
go back to reference Sato H, Feix JB, Frank DW (2006) Identification of superoxide dismutase as a cofactor for the Pseudomonas type III toxin, ExoU. Biochemistry 45:10368–10375CrossRefPubMed Sato H, Feix JB, Frank DW (2006) Identification of superoxide dismutase as a cofactor for the Pseudomonas type III toxin, ExoU. Biochemistry 45:10368–10375CrossRefPubMed
6.
go back to reference Anderson DM, Schmalzer KM, Sato H, Casey M, Terhune SS, Haas AL et al (2011) Ubiquitin and ubiquitin-modified proteins activate the Pseudomonas aeruginosa T3SS cytotoxin, ExoU. Mol Microbiol 82:1454–1467PubMedCentralCrossRefPubMed Anderson DM, Schmalzer KM, Sato H, Casey M, Terhune SS, Haas AL et al (2011) Ubiquitin and ubiquitin-modified proteins activate the Pseudomonas aeruginosa T3SS cytotoxin, ExoU. Mol Microbiol 82:1454–1467PubMedCentralCrossRefPubMed
7.
go back to reference Tyson GH, Hauser AR (2013) Phosphatidylinositol 4,5-bisphosphate is a novel coactivator of the Pseudomonas aeruginosa cytotoxin ExoU. Infect Immun 81:2873–2881PubMedCentralCrossRefPubMed Tyson GH, Hauser AR (2013) Phosphatidylinositol 4,5-bisphosphate is a novel coactivator of the Pseudomonas aeruginosa cytotoxin ExoU. Infect Immun 81:2873–2881PubMedCentralCrossRefPubMed
8.
9.
go back to reference Saliba AM, Nascimento DO, Silva MCA, Assis MC, Gayer CRM, Raymond B et al (2005) Eicosanoid-mediated proinflammatory activity of Pseudomonas aeruginosa ExoU. Cell Microbiol 7:1811–1822CrossRefPubMed Saliba AM, Nascimento DO, Silva MCA, Assis MC, Gayer CRM, Raymond B et al (2005) Eicosanoid-mediated proinflammatory activity of Pseudomonas aeruginosa ExoU. Cell Microbiol 7:1811–1822CrossRefPubMed
10.
go back to reference Plotkowski MC, Feliciano LF, Machado GB, Cunha LG Jr, Freitas C, Saliba AM et al (2008) ExoU-induced procoagulant activity in Pseudomonas aeruginosa-infected airway cells. Eur Respir J 32:1591–1598CrossRefPubMed Plotkowski MC, Feliciano LF, Machado GB, Cunha LG Jr, Freitas C, Saliba AM et al (2008) ExoU-induced procoagulant activity in Pseudomonas aeruginosa-infected airway cells. Eur Respir J 32:1591–1598CrossRefPubMed
11.
go back to reference Machado GBS, Oliveira AV, Saliba AM, de Lima CDM, Suassuna JH, Plotkowski MC (2011) Pseudomonas aeruginosa toxin ExoU induces a PAF-dependent impairment of alveolar fibrin turnover secondary to enhanced activation of coagulation and increased expression of plasminogen activator inhibitor-1 in the course of mice pneumosepsis. Respir Res 12:104PubMedCentralCrossRefPubMed Machado GBS, Oliveira AV, Saliba AM, de Lima CDM, Suassuna JH, Plotkowski MC (2011) Pseudomonas aeruginosa toxin ExoU induces a PAF-dependent impairment of alveolar fibrin turnover secondary to enhanced activation of coagulation and increased expression of plasminogen activator inhibitor-1 in the course of mice pneumosepsis. Respir Res 12:104PubMedCentralCrossRefPubMed
12.
go back to reference de Lima CDM, Calegari-Silva TC, Pereira RM, Santos SA, Lopes UG, Plotkowski MC et al (2012) ExoU activates NF-κB and increases IL-8/KC secretion during Pseudomonas aeruginosa infection. PLoS One 7:e41772PubMedCentralCrossRefPubMed de Lima CDM, Calegari-Silva TC, Pereira RM, Santos SA, Lopes UG, Plotkowski MC et al (2012) ExoU activates NF-κB and increases IL-8/KC secretion during Pseudomonas aeruginosa infection. PLoS One 7:e41772PubMedCentralCrossRefPubMed
13.
go back to reference Mallet de Lima CD, da Conceição Costa J, de Oliveira Lima Santos SA, Carvalho S, de Carvalho L, Albano RM et al (2014) Central role of PAFR signalling in ExoU-induced NF-κB activation. Cell Microbiol 16:1244–1254CrossRefPubMed Mallet de Lima CD, da Conceição Costa J, de Oliveira Lima Santos SA, Carvalho S, de Carvalho L, Albano RM et al (2014) Central role of PAFR signalling in ExoU-induced NF-κB activation. Cell Microbiol 16:1244–1254CrossRefPubMed
14.
go back to reference Diaz MH, Shaver CM, King JD, Musunuri S, Kazzaz JA, Hauser AR (2008) Pseudomonas aeruginosa induces localized immunosuppression during pneumonia. Infect Immun 76:4414–4421PubMedCentralCrossRefPubMed Diaz MH, Shaver CM, King JD, Musunuri S, Kazzaz JA, Hauser AR (2008) Pseudomonas aeruginosa induces localized immunosuppression during pneumonia. Infect Immun 76:4414–4421PubMedCentralCrossRefPubMed
15.
16.
go back to reference Machado GB, de Assis MC, Leão R, Saliba AM, Silva MC, Suassuna JH et al (2010) ExoU-induced vascular hyperpermeability and platelet activation in the course of experimental Pseudomonas aeruginosa pneumosepsis. Shock 33:315–321CrossRefPubMed Machado GB, de Assis MC, Leão R, Saliba AM, Silva MC, Suassuna JH et al (2010) ExoU-induced vascular hyperpermeability and platelet activation in the course of experimental Pseudomonas aeruginosa pneumosepsis. Shock 33:315–321CrossRefPubMed
17.
go back to reference Rochelle LG, Fischer BM, Adler KB (1998) Concurrent production of reactive oxygen and nitrogen species by airway epithelial cells in vitro. Free Radic Biol Med 15:863–868CrossRef Rochelle LG, Fischer BM, Adler KB (1998) Concurrent production of reactive oxygen and nitrogen species by airway epithelial cells in vitro. Free Radic Biol Med 15:863–868CrossRef
18.
go back to reference Jeon DS, Ha EY, Mun KC (2012) Effects of cyclosporine on oxidative stress in human bronchial epithelial cells. Transplant Proc 44:988–990CrossRefPubMed Jeon DS, Ha EY, Mun KC (2012) Effects of cyclosporine on oxidative stress in human bronchial epithelial cells. Transplant Proc 44:988–990CrossRefPubMed
19.
go back to reference Pace E, Ferraro M, Di Vincenzo S, Gerbino S, Bruno A, Lanata L et al (2014) Oxidative stress and innate immunity responses in cigarette smoke stimulated nasal epithelial cells. Toxicol In Vitro 28:292–299CrossRefPubMed Pace E, Ferraro M, Di Vincenzo S, Gerbino S, Bruno A, Lanata L et al (2014) Oxidative stress and innate immunity responses in cigarette smoke stimulated nasal epithelial cells. Toxicol In Vitro 28:292–299CrossRefPubMed
20.
go back to reference Del Rio D, Stewart AJ, Pellegrini N (2005) A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 15:316–328CrossRefPubMed Del Rio D, Stewart AJ, Pellegrini N (2005) A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 15:316–328CrossRefPubMed
21.
go back to reference Janssen LJ (2001) Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 280:L1067–L1082PubMed Janssen LJ (2001) Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 280:L1067–L1082PubMed
22.
go back to reference Romero PV, Rodríguez B, Martínez S, Cañizares R, Sepúlveda D, Manresa F (2006) Analysis of oxidative stress in exhaled breath condensate from patients with severe pulmonary infections. Arch Bronconeumol 2:113–119 Romero PV, Rodríguez B, Martínez S, Cañizares R, Sepúlveda D, Manresa F (2006) Analysis of oxidative stress in exhaled breath condensate from patients with severe pulmonary infections. Arch Bronconeumol 2:113–119
23.
24.
go back to reference Wang L, Taneja R, Razavi HM, Law C, Gillis C, Mehta S (2012) Specific role of neutrophil inducible nitric oxide synthase in murine sepsis-induced lung injury in vivo. Shock 37:539–547CrossRefPubMed Wang L, Taneja R, Razavi HM, Law C, Gillis C, Mehta S (2012) Specific role of neutrophil inducible nitric oxide synthase in murine sepsis-induced lung injury in vivo. Shock 37:539–547CrossRefPubMed
25.
go back to reference MacNee W (2001) Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 429:195–207CrossRefPubMed MacNee W (2001) Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 429:195–207CrossRefPubMed
26.
go back to reference Zhang ZQ, Song YL, Chen ZH, Shen Y, Bai CX (2011) Deletion of aquaporin 5 aggravates acute lung injury induced by Pseudomonas aeruginosa. J Trauma 71:1305–1311CrossRefPubMed Zhang ZQ, Song YL, Chen ZH, Shen Y, Bai CX (2011) Deletion of aquaporin 5 aggravates acute lung injury induced by Pseudomonas aeruginosa. J Trauma 71:1305–1311CrossRefPubMed
27.
go back to reference Junkins RD, Carrigan SO, Wu Z, Stadnyk AW, Cowley E, Issekutz T et al (2014) Mast cells protect against Pseudomonas aeruginosa-induced lung injury. Am J Pathol 184:2310–2321CrossRefPubMed Junkins RD, Carrigan SO, Wu Z, Stadnyk AW, Cowley E, Issekutz T et al (2014) Mast cells protect against Pseudomonas aeruginosa-induced lung injury. Am J Pathol 184:2310–2321CrossRefPubMed
28.
go back to reference Kurahashi K, Kajikawa O, Sawa T, Ohara M, Gropper MA, Frank DW et al (1999) Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J Clin Invest 104:743–750PubMedCentralCrossRefPubMed Kurahashi K, Kajikawa O, Sawa T, Ohara M, Gropper MA, Frank DW et al (1999) Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J Clin Invest 104:743–750PubMedCentralCrossRefPubMed
29.
go back to reference Fu P, Mohan V, Mansoor S, Tiruppathi C, Sadikot RT, Natarajan V (2013) Role of nicotinamide adenine dinucleotide phosphate-reduced oxidase proteins in Pseudomonas aeruginosa-induced lung inflammation and permeability. Am J Respir Cell Mol Biol 48:477–488PubMedCentralCrossRefPubMed Fu P, Mohan V, Mansoor S, Tiruppathi C, Sadikot RT, Natarajan V (2013) Role of nicotinamide adenine dinucleotide phosphate-reduced oxidase proteins in Pseudomonas aeruginosa-induced lung inflammation and permeability. Am J Respir Cell Mol Biol 48:477–488PubMedCentralCrossRefPubMed
30.
go back to reference Chatterjee S, Feinstein SI, Dodia C, Sorokina E, Lien YC, Nguyen S et al (2011) Peroxiredoxin 6 phosphorylation and subsequent phospholipase A2 activity are required for agonist-mediated activation of NADPH oxidase in mouse pulmonary microvascular endothelium and alveolar macrophages. J Biol Chem 286:11696–11706PubMedCentralCrossRefPubMed Chatterjee S, Feinstein SI, Dodia C, Sorokina E, Lien YC, Nguyen S et al (2011) Peroxiredoxin 6 phosphorylation and subsequent phospholipase A2 activity are required for agonist-mediated activation of NADPH oxidase in mouse pulmonary microvascular endothelium and alveolar macrophages. J Biol Chem 286:11696–11706PubMedCentralCrossRefPubMed
31.
go back to reference Ellison MA, Thurman GW, Ambruso DR (2012) Phox activity of differentiated PLB-985 cells is enhanced, in an agonist specific manner, by the PLA2 activity of Prdx6-PLA2. Eur J Immunol 42:1609–1617CrossRefPubMed Ellison MA, Thurman GW, Ambruso DR (2012) Phox activity of differentiated PLB-985 cells is enhanced, in an agonist specific manner, by the PLA2 activity of Prdx6-PLA2. Eur J Immunol 42:1609–1617CrossRefPubMed
32.
go back to reference Lange M, Nakano Y, Traber DL, Hamahata A, Esechie A, Jonkam C et al (2010) Role of different nitric oxide synthase isoforms in a murine model of acute lung injury and sepsis. Biochem Biophys Res Commun 399:286–291CrossRefPubMed Lange M, Nakano Y, Traber DL, Hamahata A, Esechie A, Jonkam C et al (2010) Role of different nitric oxide synthase isoforms in a murine model of acute lung injury and sepsis. Biochem Biophys Res Commun 399:286–291CrossRefPubMed
33.
go back to reference Xu JF, Qu JM, Li HP (2011) N-acetylcysteine modulates acute lung injury induced by Pseudomonas aeruginosa in rats. Clin Exp Pharmacol Physiol 38:345–351CrossRefPubMed Xu JF, Qu JM, Li HP (2011) N-acetylcysteine modulates acute lung injury induced by Pseudomonas aeruginosa in rats. Clin Exp Pharmacol Physiol 38:345–351CrossRefPubMed
34.
go back to reference Lange M, Connelly R, Traber DL, Hamahata A, Nakano Y, Esechie A et al (2010) Time course of nitric oxide synthases, nitrosative stress, and poly(ADP ribosylation) in an ovine sepsis model. Crit Care 14:R129PubMedCentralCrossRefPubMed Lange M, Connelly R, Traber DL, Hamahata A, Nakano Y, Esechie A et al (2010) Time course of nitric oxide synthases, nitrosative stress, and poly(ADP ribosylation) in an ovine sepsis model. Crit Care 14:R129PubMedCentralCrossRefPubMed
36.
go back to reference Leonarduzzi G, Arkan MC, Başağa H, Chiarpotto E, Sevanian A, Poli G (2000) Lipid oxidation products in cell signaling. Free Radic Biol Med 28:1370–1378CrossRefPubMed Leonarduzzi G, Arkan MC, Başağa H, Chiarpotto E, Sevanian A, Poli G (2000) Lipid oxidation products in cell signaling. Free Radic Biol Med 28:1370–1378CrossRefPubMed
37.
go back to reference Guo RF, Ward PA (2007) Role of oxidants in lung injury during sepsis. Antioxid Redox Signal 9:1991–2002CrossRefPubMed Guo RF, Ward PA (2007) Role of oxidants in lung injury during sepsis. Antioxid Redox Signal 9:1991–2002CrossRefPubMed
38.
39.
go back to reference Hosakote YM, Liu T, Castro SM, Garofalo RP, Casola A (2009) Respiratory syncytial virus induces oxidative stress by modulating antioxidant enzymes. Am J Respir Cell Mol Biol 41:348–357PubMedCentralCrossRefPubMed Hosakote YM, Liu T, Castro SM, Garofalo RP, Casola A (2009) Respiratory syncytial virus induces oxidative stress by modulating antioxidant enzymes. Am J Respir Cell Mol Biol 41:348–357PubMedCentralCrossRefPubMed
Metadata
Title
ExoU-induced redox imbalance and oxidative stress in airway epithelial cells during Pseudomonas aeruginosa pneumosepsis
Authors
Luiz Gonzaga da Cunha Jr.
Miriam Francisca Ferreira
João Alfredo de Moraes
Patricia Alves Reis
Hugo Caire Castro-Faria-Neto
Christina Barja-Fidalgo
Maria-Cristina Plotkowski
Alessandra Mattos Saliba
Publication date
01-12-2015
Publisher
Springer Berlin Heidelberg
Published in
Medical Microbiology and Immunology / Issue 6/2015
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-015-0418-x

Other articles of this Issue 6/2015

Medical Microbiology and Immunology 6/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.